Back
Skye Bioscience Vs. Oramed Pharmaceuticals Industry Stock Comparison
Buy
53
SKYE
Skye Bioscience
Last Price:
4.96
Seasonality Move:
74.8%
Sell
39
ORMP
Oramed Pharmaceuticals
Last Price:
2.22
Seasonality Move:
22.85%
Buy
53
Skye Bioscience (SKYE)
is a Buy
Is Skye Bioscience a Buy, Sell or Hold?
- The current Skye Bioscience [SKYE] share price is $5.51. The Score for SKYE is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- SKYE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
39
Oramed Pharmaceuticals (ORMP)
is a Sell
Is Oramed Pharmaceuticals a Buy, Sell or Hold?
- The current Oramed Pharmaceuticals [ORMP] share price is $2.34. The Score for ORMP is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- ORMP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SKYE Stock Price Chart
What is Skye Bioscience's stock price today?
-
The Skye Bioscience share price today is $5.51
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SKYE is experiencing slight buying pressure.
ORMP Stock Price Chart
What is Oramed Pharmaceuticals's stock price today?
-
The Oramed Pharmaceuticals share price today is $2.34
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ORMP is experiencing slight selling pressure.
SKYE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.23 | Buy |
| Relative Strength Index (14 RSI): | 58.94 | Buy |
| Chaikin Money Flow: | 6656 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.49 - 5.53) | Buy |
| Bollinger Bands (100): | (4.34 - 6.48) | Buy |
ORMP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 47.89 | Sell |
| Chaikin Money Flow: | -14355 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.33 - 2.39) | Sell |
| Bollinger Bands (100): | (2.33 - 2.51) | Sell |
SKYE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.45 | Buy |
| 20-day SMA: | 5.23 | Buy |
| 50-day SMA: | 4.85 | Buy |
| 200-day SMA: | 8.38 | Sell |
| 8-day EMA: | 5.42 | Buy |
| 20-day EMA: | 5.19 | Buy |
| 50-day EMA: | 5.15 | Buy |
| 200-day EMA: | 6.5 | Sell |
ORMP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.34 | Sell |
| 20-day SMA: | 2.35 | Sell |
| 50-day SMA: | 2.38 | Sell |
| 200-day SMA: | 2.52 | Sell |
| 8-day EMA: | 2.34 | Sell |
| 20-day EMA: | 2.35 | Sell |
| 50-day EMA: | 2.37 | Sell |
| 200-day EMA: | 2.51 | Sell |
Skye Bioscience Earnings Growth & SKYE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.45 per share, and a decrease next year of $0.18 per share.
Oramed Pharmaceuticals Earnings Growth & ORMP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.38 per share, and a decrease next year of $0.43 per share.
Skye Bioscience Technical Analysis
| Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Oramed Pharmaceuticals Technical Analysis
| Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||